Centrose LLC

Website Links

Description

Kevin Kaster J.D. Mr. Kaster has over 25 years of experience in both smaller biotechnology firms and large pharmaceutical companies. He has an impressive track record of developing effective patent and licensing strategies for important technologies and drug products. Mr. Kaster was formerly the VP Intellectual Properties at Kosan Biosciences, which had geldanamycin and epothilone anti-cancer agents in its pipeline and was acquired by Bristol-Myers Squibb in 2008. Prior to Kosan, he was the VP of Intellectual Property at Geron Corporation.

Mary E. Holland Ms. Holland is the Vice President of Business Development at Centrose and brings years of experience in creating and expanding market segments for Biotechnology Companies focused on developing and marketing of core product lines. Ms. Holland has served in multiple leadership roles while solidifying product acceptance during IPO or merger/acquisition transitions. Ms. Holland brings extensive experience in sales and marketing and has successfully developed multiple product lines for companies with unique technology platforms. Ms.

Homer Pearce Ph.D. Dr. Pearce recently retired from Lilly Research Laboratories where he served as Vice President of Cancer Research and Clinical Investigation and Distinguished Research Fellow. Dr. Pearce has more than 27 years of experience in cancer drug discovery and was involved in the development of more than 25 investigational drugs which entered clinical trials for cancer, of which three have resulted in regulatory approvals and others are still in development. These drugs, which include Gemzar and Alimta, achieved 2007 combined worldwide sales exceeding $2 billion.

About Centrose Centrose is a biotechnology company focused on the development and commercialization of new technologies that improve patient health.

Products & services

Similar companies nearby